S

Saurabh Dahiya

Stanford University

ORCID: 0000-0001-8291-1796

Publishes on CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Immune Cell Function and Interaction. 362 papers and 5.6k citations.

PubIndex Score95Top 5% · mid-careerHow it's scored

362Publications

5.6kTotal Citations

First publication: 1990First senior author: 2012

CAR-T cell therapy research Lymphoma Diagnosis and Treatment Immune Cell Function and Interaction Autoimmune and Inflammatory Disorders Research Biosimilars and Bioanalytical Methods

Top publicationsby citations

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Frederick L. Locke, Lazaros J. Lekakis et al.|Journal of Clinical Oncology|2020

Cited by 782

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Franck Morschhauser, Loretta J. Nastoupil, Saurabh Dahiya et al.|Nature Medicine|2024

Cited by 127

Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) As Second-Line (2L) Therapy in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): First Results from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

María Silvina Odstrcil Bobillo, Matthew J. Frigault, Swetha Kambhampati et al.|Blood|2024

Cited by 7

Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma

Jennifer L. Crombie, Iris Isufi, Sairah Ahmed et al.|Blood|2026

Cited by 1